![Kawasaki disease in 2019—past controversies, present insights and future directions - Grignani - Pediatric Medicine Kawasaki disease in 2019—past controversies, present insights and future directions - Grignani - Pediatric Medicine](http://cdn.amegroups.cn/journals/jrh/files/journals/34/articles/4767/public/4767-PB4-1063-R1.png)
Kawasaki disease in 2019—past controversies, present insights and future directions - Grignani - Pediatric Medicine
![Long-Term Prognosis of Patients With Kawasaki Disease Complicated by Giant Coronary Aneurysms | Circulation Long-Term Prognosis of Patients With Kawasaki Disease Complicated by Giant Coronary Aneurysms | Circulation](https://www.ahajournals.org/cms/asset/d1ac87ac-e6a8-4d1f-8d42-d6cec4f400ed/zhc0171193980003.jpeg)
Long-Term Prognosis of Patients With Kawasaki Disease Complicated by Giant Coronary Aneurysms | Circulation
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/68ca0cc8-ba61-4bb5-aa35-b798530f3551/e927fig03.gif)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
![Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre | Open Heart Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre | Open Heart](https://openheart.bmj.com/content/openhrt/2/1/e000206/F2.large.jpg)
Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre | Open Heart
![PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease](https://www.researchgate.net/publication/259920812/figure/fig1/AS:203195105189888@1425456896344/Cumulative-survival-rate-of-patients-with-hemophagocyticlymphohistiocytosis-following_Q320.jpg)
PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease
![Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics](https://www.frontiersin.org/files/Articles/431147/fped-07-00011-HTML/image_m/fped-07-00011-g004.jpg)
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics
![PDF) Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study PDF) Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study](https://www.researchgate.net/profile/Liang-Jen_Wang/publication/282126191/figure/fig2/AS:352477665873921@1461048632578/ADHD-free-survival-rates-for-the-patients-with-Kawasaki-disease-and-comparison-cohort_Q320.jpg)
PDF) Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study
![An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0e3f6c87-dc67-4e34-902f-7c06a83dd05d/gr1_lrg.jpg)